Agonist-Dependent Modulation by the Long-Acting Mu Opioid Receptor Antagonist, Methocinnamox (MCAM)

被引：1
|
作者：
Smith, Hudson [1 ]
Zamora, Joshua [1 ]
Chavera, Teresa [1 ]
Jennings, Elaine [1 ]
Winger, Gail [1 ]
Woods, James [1 ]
Clarke, William [1 ]
Berg, Kelly [1 ]
机构：
[1] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA
来源：
FASEB JOURNAL | 2020年 / 34卷
关键词：
D O I：
10.1096/fasebj.2020.34.s1.06832
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Methocinnamox (MCAM) is a Selective, Long Acting Antagonist at Mu Opioid Receptor In Vitro
    Zamora, Joshua C.
    Kotipalli, Varun
    Jennings, Elaine M.
    Disney, Alex
    Husbands, Stephen
    Winger, Gail
    Clarke, William P.
    Woods, James H.
    Berg, Kelly A.
    [J]. FASEB JOURNAL, 2019, 33
  • [2] Long-Term Inhibition of mu Opioid Receptor Function In Vitro and In Vivo by Methocinnamox (MCAM), a Long Acting mu Opioid Receptor Antagonist
    Berg, Kelly
    Zamora, Joshua
    Jennings, Elaine
    Varun, Kotipalli
    Gail, Winger
    Stephen, Husbands
    Disney, Alex
    Clarke, William
    Woods, James
    [J]. NEUROPSYCHOPHARMACOLOGY, 2018, 43 : S372 - S372
  • [3] Methocinnamox (MCAM) is an Effective Long-Term Antagonist of Peripheral Mu, but not Kappa or Delta Opioid Receptors In Vivo
    Jennings, Elaine M.
    Disney, Alex
    Husbands, Stephen
    Winger, Gail
    Berg, Kelly A.
    Clarke, William P.
    Woods, James H.
    [J]. FASEB JOURNAL, 2019, 33
  • [4] METHOCINNAMOX (MCAM): A NOVEL μ OPIOID RECEPTOR ANTAGONIST FOR TREATING OPIOID USE DISORDER AND OPIOID OVERDOSE
    France, C. P.
    Gerak, L. R.
    Maguire, D. R.
    Javors, M. A.
    Woods, J. H.
    Husbands, S. M.
    Disney, A.
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2019, 43 : 354A - 354A
  • [5] Effects of Methocinnamox, a Long-Acting Mu Opioid Receptor Antagonist, on Fentanyl Choice in Monkeys Responding Under a Food Versus Drug Choice Procedure
    Maguire, David
    France, Charles
    [J]. NEUROPSYCHOPHARMACOLOGY, 2022, 47 : 474 - 474
  • [6] Ligand-Dependent Reversal Kinetics of Mu Opioid Receptor Agonists by the Novel Antagonist, Methocinnamox
    Smith, Hudson R.
    Chavera, Teresa S.
    Berg, Kelly A.
    Clarke, William P.
    [J]. FASEB JOURNAL, 2022, 36
  • [7] Long-term Antagonism of <it>Mu</it> Opioid Receptors by Methocinnamox (MCAM) without Adverse Effects on Memory
    Minervini, Vanessa
    France, Charles
    [J]. FASEB JOURNAL, 2020, 34
  • [8] Agonist-dependent modulation of arterial endothelinA receptor function
    Compeer, M. G.
    Meens, M. J. P. M. T.
    Hackeng, T. M.
    Neugebauer, W. A.
    Hoeltke, C.
    De Mey, J. G. R.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2012, 166 (06) : 1833 - 1845
  • [9] Role of agonist-dependent receptor internalization in the regulation of μ opioid receptors
    Sternini, C
    Brecha, NC
    Minnis, J
    D'Agostino, G
    Balestra, B
    Fiori, E
    Tonini, M
    [J]. NEUROSCIENCE, 2000, 98 (02) : 233 - 241
  • [10] Agonist-dependent development of delta opioid receptor tolerance in the colon
    DiCello, Jesse J.
    Saito, Ayame
    Rajasekhar, Pradeep
    Sebastian, Benjamin W.
    McQuade, Rachel M.
    Gondin, Arisbel B.
    Veldhuis, Nicholas A.
    Canals, Meritxell
    Carbone, Simona E.
    Poole, Daniel P.
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2019, 76 (15) : 3033 - 3050
12345